NATURES SUNSHINE PRODUCTS INC (NATR)
Pharmaceutical Preparations · Healthcare · $353M
Intrinsic Value (Consensus)
$14.48
Current Price
$20.08
Margin of Safety
-27.9%
27.9% Above Intrinsic Value
Value: $14
Price: $20
Valuation Model Estimates
Current Price: $20.08
DCF (Discounted Cash Flow)
$77.00
Graham Number
$11.96
Earnings Power Value
$10.29
Relative Value (P/E)
$21.20
Dividend Discount Model
Not applicable
—
Consensus Value
$14.48
Model Assumptions
Discount Rate
10.3%
Growth Rate
20.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
B
71
Profitability
22/25
Strength
24/25
Valuation
9/25
Growth
16/25
Financial Health Signals
Low debt — conservative balance sheet
Strong earnings growth (20% YoY)
High free cash flow yield (8.2%) — generating lots of cash relative to price
Key Financials
- EPS (TTM)
- $1.06
- EPS (Forward)
- $1.27
- Book Value
- $5.99
- P/E Ratio
- 20.0
- Forward P/E
- 16.7
- PEG Ratio
- —
- ROE
- 18.5%
- Debt/Equity
- 1%
- Revenue Growth
- 5.7%
- Earnings Growth
- 20.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance